Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection-Reference-Cited by-同舟云学术

Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection

Published:2020-06-26 Issue:10 Volume:27 Page:974-986
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Dietz Julia¹²^ORCID,Kalinina Olga V.³⁴,Vermehren Johannes¹²,Peiffer Kai‐Henrik¹²,Matschenz Katrin⁵,Buggisch Peter⁵,Niederau Claus⁶,Schattenberg Jörn M.⁷,Müllhaupt Beat⁸,Yerly Sabine⁹,Ringelhan Marc¹⁰,Schmid Roland M.¹⁰,Antoni Christoph¹¹,Müller Tobias¹²,Schulze zur Wiesch Julian¹³¹⁴^ORCID,Piecha Felix¹³,Moradpour Darius¹⁵,Deterding Katja¹⁶¹⁷¹⁸,Wedemeyer Heiner¹⁶¹⁷¹⁸,Moreno Christophe¹⁹,Berg Thomas²⁰,Berg Christoph P.²¹,Zeuzem Stefan¹²,Welsch Christoph¹²,Sarrazin Christoph¹²²²,

Affiliation:

1. Department of Internal 1 University Hospital Goethe University Frankfurt Germany

2. German Center for Infection Research (DZIF), External Partner Site Frankfurt Germany

3. Helmholtz Centre for Infection Research (HZI) Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Saarbrücken Germany

4. Medical Faculty Saarland University Homburg Germany

5. Institute for Interdisciplinary Medicine IFI Hamburg Germany

6. St. Josef‐Hospital Katholisches Klinikum Oberhausen Oberhausen Germany

7. Department of Internal Medicine I University Medical Center of the Johannes Gutenberg‐University Mainz Germany

8. Swiss Hepato‐Pancreato‐Biliary Center and Department of Gastroenterology and Hepatology University Hospital Zürich Zürich Switzerland

9. Laboratory of Virology University Hospital Geneva University of Geneva Geneva Switzerland

10. Department of Internal Medicine II Klinikum rechts der Isar Technische Universität München Munich Germany

11. Department of Medicine II Heidelberg University Hospital at Mannheim Mannheim Germany

12. Department of Hepatology and Gastroenterology Charité Universitätsmedizin Berlin Berlin Germany

13. Department of Internal Medicine I University Medical Center Hamburg‐Eppendorf Hamburg Germany

14. German Center for Infection Research (DZIF), Partner Site, Hamburg-Lübeck-Borstel-Riems HamburgGermany

15. Division of Gastroenterology and Hepatology University Hospital Lausanne Lausanne Switzerland

16. Department of Gastroenterology and Hepatology University Hospital Essen Essen Germany

17. Department of Gastroenterology, Hepatology and Endocrinology Medizinische Hochschule Hannover Hannover Germany

18. German Center for Infection Research (DZIF), Partner Site, Hannover-Braunschweig Hannover Germany

19. Department of Gastroenterology, Hepatopancreatology and Digestive Oncology CUB Hôpital Erasme Université Libre de Bruxelles Brussels Belgium

20. Department of Gastroenterology and Rheumatology University Hospital Leipzig Leipzig Germany

21. Department of Internal Medicine I University of Tübingen Tübingen Germany

22. St. Josefs‐Hospital Medizinische Klinik II Wiesbaden Germany

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13322

Reference49 articles.

1. Eliminating hepatitis C within low-income countries – The need to cure genotypes 4, 5, 6

2. Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r

3. Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis

4. Hepatitis C genotype 4: What we know and what we don't yet know

5. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

2. ‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment;Gut;2024-05-23

3. Personalized care approaches to hepatitis C therapy: recent advances and future directions;Expert Review of Anti-infective Therapy;2024-03-11

4. Genotype 4 hepatitis C virus-a review of a diverse genotype;Advances in Medical Sciences;2023-03

5. Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial;The Lancet Gastroenterology & Hepatology;2022-06